[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"RxFunction Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":100},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,48,76],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100589812","balance4mobility-effects-of-walkasins-use-in-individuals-with-peripheral-neuropathy-and-balance-problems-100589812",false,"NCT06959277","Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems","Balance4Mobility: Effects of Walkasins Use on Clinical Outcomes of Gait and Balance Function in Individuals With Peripheral Neuropathy and Balance Problems - A Randomized Control Trial","Inclusion Criteria:\n\n* Able to understand and provide informed consent for him or herself\n* Age 55 and older, male or female\n* Able to complete all functional outcome measures without the use of an assistive device\n* Clinical diagnosis of peripheral neuropathy prior to participating in the study as documented in the participant's medical record or by physician's note. Individuals with chemo-induced peripheral neuropathy must be at least one-year post-chemotherapy, indicating that their PN has become a chronic condition.\n* Self-reported gait and balance problems\n* Foot size that allows the Walkasins to function appropriately\n* Willing to use the Walkasins device as recommended\n\nExclusion Criteria:\n\n* Ability to stand on one leg for at least 30 seconds (If the person can stand for at least 30 seconds, he\u002Fshe is excluded because his\u002Fher balance is likely not impaired enough to benefit from Walkasins.)\n* Self-reported acute thrombophlebitis, including deep vein thrombosis\n* Self-reported severe peripheral vascular disease\n* Untreated lymphedema\n* Untreated lesion of any kind, swelling, infection, inflamed area of skin or eruptions on the lower leg near product use\n* Self-reported, untreated fractures in the foot and ankle\n* Other neurological or musculoskeletal conditions that moderately or severely impact walking\n* Use of ankle-foot orthosis for ambulation that prevents donning of Walkasins\n* Weight of more than 300 pounds\n* Inability to perceive vibration from Walkasins Haptic Module","ALL","55 Years",{"count":19,"type":20},200,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to is to test whether Walkasins can help people with peripheral neuropathy maintain their balance better. The main question it aims to answer is whether participants who use Walkasins on an everyday basis over a six-month period will report better awareness of their foot placement on the ground.\n\nResearchers will compare Walkasins users to a control group of participants who are not using Walkasins to see if the device improves the users' performance on some standing and walking tests. Control group participants will get Walkasins after six months of being in the study.\n\nDuring the study participants will be asked to do the following:\n\n* Answer questions about their medical history and balance.\n* Do some standing and walking tests. Some of the tests will be timed.\n* Attend study visits and participate in study phone calls.\n* Keep track of any falls and notify study staff if they fall.\n* Wear the Walkasins device on a regular basis.",[26,27,28,29,30],"Peripheral Neuropathies","Peripheral Neuropathy Due to Chemotherapy","Peripheral Neuropathy With Type 2 Diabetes","Balance Control in Elderly","Gait Disorders",[32,33,34],"Walkasins","Peripheral Neuropathy","Balance Problems","RECRUITING","2026-06-23",{"date":38,"type":39},"2026-06-24","ACTUAL",{"date":41,"type":39},"2025-06-17",{"date":43,"type":20},"2027-12-31",{"name":45,"class":46},"RxFunction Inc.","INDUSTRY",6,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":16,"minAge":55,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":21,"phases":58,"briefSummary":59,"conditions":60,"keywords":66,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},"100635573","wearable-sensory-prosthesis-to-improve-coordination-walking-and-physical-activity-100635573","NCT07554443","Wearable Sensory Prosthesis to Improve Coordination, Walking, and Physical Activity","Wearable Sensory Prostheses to Improve Neuromuscular Coordination, Walking Function, and Real-World Physical Activity","Inclusion Criteria:\n\n* Be 60 years of age or older\n* Have a diagnosis of PN with plantar sensory loss\n* Demonstrate balance impairment, defined as a Single-Leg Stance time of \\\u003C23 seconds\n* Be able to walk independently for at least 6 minutes without the use of an assistive device (rest breaks permitted)\n* Be willing to use the Walkasins device as recommended\n* Be willing to participate in all aspects of physical activity monitoring and study assessments\n\nExclusion Criteria:\n\n* Under 60 years old\n* Do not have a diagnosis of PN with plantar sensory loss\n* Self-reported acute thrombophlebitis, including deep vein thrombosis\n* Self-reported severe peripheral vascular disease\n* Untreated lymphedema\n* Untreated lesion of any kind, swelling, infection, inflamed area of skin or eruptions on the lower leg near product use\n* Self-reported, untreated fractures in the foot and ankle\n* Other neurological or musculoskeletal conditions that moderately or severely impact walking\n* Use of ankle-foot orthosis for ambulation that prevents donning of Walkasins\n* Weight of more than 300 pounds\n* Inability to perceive vibration from Walkasins Haptic Module\n* Do not demonstrate balance impairments, defined as a Single-Leg Stance time of \\\u003C23 seconds","60 Years",{"count":57,"type":20},18,[23],"The goal of this clinical trial is to investigate whether sensory stimulations from a neuroprosthesis device (Walkasins®) can increase physical activity and improve gait quality in persons with peripheral neuropathy (PN). The main question it aims to answer is whether Walkasins enhances habitual activity patterns in adults with peripheral neuropathy.\n\nParticipants will do the following as part of the study:\n\n* Complete a sensation and balance assessment to determine eligibility for the study.\n* Answer questions about their medical history, physical function, balance confidence, and sleep.\n* Perform various balance and walking tasks on three separate occasions. One of the tests involves walking for six minutes without a cane or walker.\n* Wear an activPAL activity monitor for ten days on three separate occasions and return it to the researcher as directed.\n* Wear Walkasins for ten weeks as part of their daily routine. Walkasins consists of two parts: 1) an insole that fits inside the shoe and 2) a strap that secures around the ankle.",[28,61,62,63,64,65],"Peripheral Neuropathy Grade 2 or Greater","Balance","Balance Impairment, Gait Disorders, Fatigue","Balance Disorders","Physical Activities",[33,32,64,67],"Physical Activity","2026-06-22",{"date":70,"type":39},"2026-06-25",{"date":70,"type":20},{"date":73,"type":20},"2027-12",{"name":45,"class":46},1,{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":82,"sex":16,"minAge":83,"maxAge":4,"enrollmentInfo":84,"targetDuration":4,"studyType":86,"phases":4,"briefSummary":87,"conditions":88,"keywords":92,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":94,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":75},"100624631","hows-your-balance-100624631","NCT07412145","How's Your Balance?","Inclusion Criteria:\n\n* Adults, ages 20 and older\n* Able to provide verbal consent\n\nExclusion Criteria:\n\n* Individuals, ages 19 and younger\n* Inability to provide verbal consent",true,"20 Years",{"count":85,"type":20},1000,"OBSERVATIONAL","The goals of this observational study are to investigate the following:\n\n* If there is a relationship between prior falls, single leg stance time, and plantar cutaneous sensitivity as measured by monofilaments.\n* Plantar sensitivity across a broad range of ages.\n* Self-reported physical function related to balance and mobility using the PROMIS® PROWalk™ questionnaire and balance confidence using the Activities-specific Balance Confidence Scale-6 (ABC-6).\n\nParticipants will answer questions about themselves and their balance and falls. Their plantar (bottom of their feet) sensation will also be tested using monofilaments. And they will stand on a force plate with their eyes open and closed in dual and single leg stances for up to 30 seconds.",[89,90,91],"Balance Assessment","Falls","Plantar Sensation",[62,90,93],"Plantar sensation",{"date":70,"type":39},{"date":96,"type":39},"2025-08-23",{"date":98,"type":20},"2028-12",{"name":45,"class":46},""]